Mirugen Overview
- Website
- www.mirugen.com
- Industry
- Biotechnology Research
- Employees
- 1
- Founded
- 2022
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Mirugen
Mirugen is a preclinical biotechnology company identifying the optimal set of cellular instructions ('transcription factors') to ask one cell type to become another. Our lead program is focused on unlocking innate repair mechanisms to restore sight, initially for the 1.5 million individuals worldwide suffering from Retinitis Pigmentosa.
Mirugen Contact Details
- People in AeroLeads
- 1
Mirugen Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Raymond Wong | Principal Investigator at Centre for Eye Research Australia and University of Melbourne | Greater Melbourne Area, Australia |
View
|
Compare Similar Companies to Mirugen
Brandon Capital
Venture Capital And Private Equity Principals
OncoRes Medical
Medical Equipment Manufacturing
ANDHealth
Hospitals And Health Care
SeeTreat Medical
Medical Equipment Manufacturing
Baymatob
Medical Equipment Manufacturing
Kinoxis Therapeutics Pty Ltd
Biotechnology Research
Misti
Biotechnology
Currus Biologics Pty Ltd
Biotechnology Research
Meizon Innovation
Biotechnology Research
Amplificare
Biotechnology Research